CLINICAL_TRIALS
ClinicalTrials.gov record update
Omic Technologies Applied to the Study of Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05834426
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:05.881332+00:00
- Published At
- 2023-06-22T00:00:00+00:00
- Record Updated At
- 2023-06-22
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Lymphoma, B-Cell", "Neoplasms", "Cancer", "High-grade B-cell Lymphoma", "Diffuse Large B Cell Lymphoma", "Non Hodgkin Lymphoma", "Metabolomics"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-06-22"- protocolSection.identificationModule.nctId
"NCT05834426"- protocolSection.identificationModule.officialTitle
"Omic Technologies Applied to the Study of Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers"- protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.